Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulopenem vs Ertapenem for cIAI
NCT03358576Phase 3Completed
- Sponsor
- Iterum Therapeutics plc
- Start
- Sep 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of sulopenem in Intra-abdominal infection (IAI), sponsored by Iterum Therapeutics plc. Started Sep 2018; status: completed.
02
Drugs
sulopenem
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT03358576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03358576.